FDA Inspection 1232144 — Lonza Biologics, Inc.
The FDA completed an inspection of Lonza Biologics, Inc. on Mar 7, 2024 in Portsmouth, NH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 7, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Portsmouth, NH (United States)